Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» When is a drug too risky to stay on the market?
When is a drug too risky to stay on the market?
When is a drug too risky to stay on the market?
Submitted by
admin
on July 1, 2010 - 9:04am
Source:
Yahoo/AP
News Tags:
GSK
Merck
Pfizer
Avandia
FDA
Tysabri
Headline:
When is a drug too risky to stay on the market?
Do Not Allow Advertisers to Use My Personal information
